GTC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Genes to Cells (2005) 10, 705-715. doi:10.1111/j.1365-2443.2005.00868.x
© 2005 Blackwell Publishing or its licensors

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimazaki, N.
Right arrow Articles by Koiwai, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimazaki, N.
Right arrow Articles by Koiwai, O.

DNA polymerase lambda directly binds to proliferating cell nuclear antigen through its confined C-terminal region

Noriko Shimazaki1,*, Takaya Yazaki1, Takashi Kubota1, Asami Sato1, Ayako Nakamura2, Shunsuke Kurei2, Shingo Toji2, Katsuyuki Tamai3 and Osamu Koiwai1

1 Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba 278-8510, Japan
2 R and D Division of Medical and Biological Laboratories, Co., Ltd, Ina, Nagano 396-0002, Japan
3 Cyclex, Co., Ltd, Ina, Nagano 396-0002, Japan


    Abstract
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
DNA polymerase lambda (Pol {lambda}) was recently identified as a new member of the family X of DNA polymerases. Here, we show that Pol {lambda} directly binds to proliferating cell nuclear antigen (PCNA), an auxiliary protein for DNA replication and repair enzymes, both in vitro and in vivo. A pull-down assay using deletion mutants of Pol {lambda} showed that the confined C-terminal region of Pol {lambda} directly binds to PCNA. Furthermore, a synthetic peptide of 20-mers derived from the C-terminal region of Pol {lambda} competes with full-length Pol {lambda} for binding to PCNA. The residues between amino acids 518 and 537 of Pol {lambda} are required for binding to PCNA, and are different from the consensus PCNA interacting motif (PIM). Pol {lambda} associates with PCNA in vivo by immunoprecipitation analysis and EGFP-tagged Pol {lambda} co-localizes with PCNA as spots within a nucleus using fluorescent microscopy. Through direct binding, PCNA suppressed the distributive nucleotidyltransferase activity of Pol {lambda}. Pol µ, which also belongs to the family X of DNA polymerases, binds to PCNA by a pivotal amino acid residue.


    Introduction
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Sixteen DNA polymerases have been found in mammalian cells, including the recently discovered DNA polymerases (Pol) {zeta}, {eta}, {theta}, {iota}, {kappa}, {lambda}, µ, {nu}, {sigma} and REV1, which are believed to specifically synthesize DNA using damaged DNA template (Hubscher et al. 2000; Burgers et al. 2001; Marini et al. 2003). The DNA polymerases are classified into four families based on their amino acid sequence homology and termed families A, B, X and Y (Ito & Braithwaite 1991; Braithwaite & Ito 1993; Burgers et al. 2001; Ohmori et al. 2001). Among the families, family X includes well-studied enzymes, Pol ß and terminal deoxynucleotidyltransferase (TdT) and newly identified Pol {lambda}, Pol µ and Pol {sigma} (Ito & Braithwaite 1991; Braithwaite & Ito 1993; Aoufouchi et al. 2000; Dominguez et al. 2000; Nagasawa et al. 2000; Wang et al. 2000). The family X of DNA polymerases (Pol X polymerases) have evolved as nucleotidyltransferases to catalyze DNA polymerization in a distributive manner (Aravind & Koonin 1999). Apart from Pol {sigma}, the Pol X polymerases are composed of a nuclear localization signal (NLS), a BRCA1 C-terminal (BRCT) domain, a proline rich region (which functions as a suppressive domain for DNA polymerase activity (SDPA)) and a Pol ß like region in their C-terminal half (Shimazaki et al. 2002). However, Pol ß lacks a NLS, a BRCT domain and a proline rich region/SDPA, which are conserved in the amino-terminal regions of other Pol X polymerases. Although Pol X polymerases share a high degree of amino acid sequence homology, the presumed functions of each member are divergent. In particular, Pol ß functions in the short-patch base excision repair (BER) pathway, which is a major pathway for repairing aprinic/apyrimidinic (AP) sites and modified bases of DNA (Wilson 1998). On the other hand, TdT expands repertories of Immunoglobulin (Ig) or T-cell receptor (TcR) gene by adding extra nucleotides at the junctions between V and D or between D and J segments during V(D)J recombination, which is a specialized form of non-homologous end joining (NHEJ) of double stranded DNA breaks (DSBs) (Gilfillan et al. 1993; Komori et al. 1993). Pol {lambda} was recently identified as a member of family X (Aoufouchi et al. 2000; Garcia-Diaz et al. 2000; Nagasawa et al. 2000). Pol {lambda} has a high degree of amino acid sequence homology to Pol ß, and conserves all the critical residues involved in DNA binding, substrate binding and the Pol X motif, which is an active center for nucleotidyltransfer. Indeed, Pol {lambda} possesses a similar enzymatic nature to Pol ß and has, apart from template preferences (Shimazaki et al. 2002) and a high affinity for dNTP (Garcia-Diaz et al. 2002), similar requirements for cations, optimal pH conditions and NaCl concentrations. Recently, the crystal structure of truncated Pol {lambda} complexed with DNA was elucidated and found to be very similar to that of Pol ß (Garcia-Diaz et al. 2004). While Pol ß shows both open and closed conformations, Pol {lambda} adopts only a closed conformation, indicating that Pol {lambda} has low processive DNA polymerase activity.

Pol ß possesses 5'-deoxyribose phosphate (dRP) lyase activity for removing dRP from AP sites and DNA polymerase activity to fill in the short gaps in the N-terminal 8 kDa and C-terminal 31 kDa domains, respectively (Matsumoto & Kim 1995; Piersen et al. 1996). These activities are required for processing in short-patch BER. Pol {lambda} also carries dRP lyase activity in vitro (Garcia-Diaz et al. 2001), suggesting that Pol {lambda} might also function in BER. Pol {lambda}-deficient mice show a defect of inner dynein arms in the cilia of ependymal and respiratory epithelium, resembling the phenotype of immotile cilia syndrome (Kobayashi et al. 2002). The functional relationship between DNA polymerase activity of Pol {lambda} and the development of inner dynein arms has not, however, been clarified. In addition, since mouse embryonic stem (ES) cells defective in Pol {lambda} seem to have no sensitivity to various DNA damaging agents, the function of Pol {lambda} could be rescued by redundancy of other DNA polymerases in ES cells. Despite these observations, recent biochemical studies have revealed that Pol {lambda} is required for gap-filling and end-joining in NHEJ of DSBs together with XRCC4-LigIV complex, which is a core component of NHEJ, as demonstrated by immunodepletion analysis using HeLa cell extracts (Lee et al. 2004) and a biochemically defined in vitro NHEJ system (Ma et al. 2004).

We first reported that Pol {lambda} directly binds to PCNA in vitro (Shimazaki et al. 2002), which was originally characterized as an accessory protein for DNA polymerase and functions as a DNA sliding clamp. Processivity of Pol {delta}, which is an essential component for eukaryotic chromosomal DNA replication, entirely depends on the PCNA by stabilizing the enzyme on a template-primer end of the replicative DNA end by specific protein–protein interactions (Einolf & Guengerich 2000). PCNA also associates with the family Y DNA polymerases Pol {eta}, Pol {iota} and Pol {kappa} (Haracska et al. 2001a, b,c, 2002). Efficiency of nucleotide incorporation with the family Y DNA polymerases is stimulated by PCNA, together with a clamp loader, replication factor C (RFC) and a single-stranded DNA binding protein, replication protein A (RPA). In contrast, we recently demonstrated an inhibitory effect of PCNA on TdT activity via direct binding through the Pol ß like region of TdT (Ibe et al. 2001).

Here, we demonstrate that a confined C-terminal region of Pol {lambda} is required for direct binding to PCNA in vitro. We also show that Pol {lambda} associates with PCNA in vivo. This direct binding of Pol {lambda} to PCNA consequently results in negative regulation for the distributive nucleotidyltransferase activity of Pol {lambda}.


    Results
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Pol {lambda} contains a confined PCNA binding region in its C-terminus

During biochemical and structural studies of human Pol {lambda}, we found that Pol {lambda} directly binds to PCNA through its catalytic domain in vitro (Shimazaki et al. 2002). To further confine the region in Pol {lambda} that directly binds to PCNA, we constructed deletion mutants of the Pol {lambda} C-terminal region. Figure 1A shows the schematic representation of the deletion mutants of Pol {lambda}. E. coli lysates expressing GST or GST fused proteins were incubated with purified recombinant PCNA and subsequently reacted with glutathione-Sepharose beads. Bound proteins were analyzed by Western blotting using anti-GST or anti-PCNA antibodies. As shown in Fig. 1B, the region composed of 56 residues (C4; residues 508–563) in the C-terminal region of Pol {lambda} was found to be the specific region for PCNA binding. The proteins that bind to PCNA usually possess a consensus PCNA interacting motif (PIM; QXX[I/L]XXF[F/Y]) (Tsurimoto 1999; Warbrick 2000). However, Pol {lambda} does not contain the typical PIM in the region between residues 508–563. The results of C3, C4 and C5 in Fig. 1 show that, despite the positive binding ability of C4, no binding was detected to C3 and C5. We therefore suspected that the residues around the C3 C-terminal or C5 N-terminal regions are crucial for binding between Pol {lambda} and PCNA. Then, we designed three kinds of peptides (LP508, 513 and 518) that were composed of 20 amino acid residues derived from the Pol {lambda} C-terminal region (Fig. 2A). To examine whether the synthetic peptides compete with the full-length Pol {lambda} for binding to PCNA, the peptides were added to the reaction mixture containing GST fused Pol {lambda} and PCNA, and a GST pull-down assay was performed. Bound proteins were analyzed by Western blotting using anti-PCNA antibodies. As shown in Fig. 2B, binding between Pol {lambda} and PCNA was inhibited in the presence of LP518 but not with LP508 and LP513. From these findings, we can deduce that the amino acid sequence from residues 518–537 is required for binding to PCNA. In particular, although 15 residues overlap between LP513 and LP518, only LP 518 was able to effectively compete with full-length Pol {lambda} for binding to PCNA. These results strongly suggest that the residues 533STAVV537 in LP 518 are crucial for binding to PCNA.



View larger version (39K):
[in this window]
[in a new window]
 
Figure 1  Pol {lambda} binds to PCNA through its C-terminal region in vitro. (A) The full-length and deletion mutants of Pol {lambda} were examined for direct binding to PCNA. The column on the right (+/–) indicates a positive/negative result when tested for binding to PCNA by a GST pull-down assay. (B) Detection of direct binding between GST fused proteins and PCNA. Glutathione Sepharose beads were mixed with purified recombinant PCNA and E. coli cell lysate expressing GST (lane 1), GST-Pol {lambda} full (lane 2), GST-Pol {lambda} F (lane 3), GST-Pol {lambda} G (lane 4), GST-Pol {lambda} H (lane 5), GST-Pol {lambda} C1 (lane 6), GST-Pol {lambda} C2 (lane 7), GST-Pol {lambda} C3 (lane 8), GST-Pol {lambda} C4 (lane 9), and GST-Pol {lambda} C5 (lane 10), respectively. Bound proteins were analyzed by immunoblotting with both anti-GST and anti-PCNA antibodies. The lane numbers on the top panel correspond to those of the bottom panel. Lane 11 of the bottom panel contained 1/25 amount of purified PCNA used in the reaction.

 


View larger version (31K):
[in this window]
[in a new window]
 
Figure 2  Competitive binding between the full-length Pol {lambda} and PCNA with synthetic peptides derived from the C-terminal region of Pol {lambda}. (A) The 20-mer peptides LP508, LP513 and LP518, which overlap between adjacent peptides, cover the putative PCNA binding region of Pol {lambda}. (B) Competitive assay of the binding between the full-length Pol {lambda} and PCNA using synthetic peptides. GST-Pol {lambda} and PCNA was mixed with the synthetic peptides LP508 (lane 3–5), LP513 (lane 6–8) and LP518 (lane 9–11), and a GST pull-down assay was performed. Bound proteins were analyzed by immunoblotting using anti-PCNA antibodies. Lane 12 contained 1/25 amount of purified PCNA used in the reaction.

 
Interdomain-connecting loop in PCNA is involved in binding to Pol {lambda}

PIM has been considered to bind to a hydrophobic pocket on the surface of PCNA and the interdomain-connecting loop (ICL) that joins the two structural domains of PCNA (Gulbis et al. 1996; Jonsson et al. 1998). In the present work, we elucidated a novel PCNA binding region in Pol {lambda}. We then asked whether or not Pol {lambda} binds to a hydrophobic pocket in PCNA. After confirmation of binding between Pol {lambda} and PCNA in yeast cells (Fig. 3A), we constructed a series of deletion mutants of human PCNA and tested whether the deletion mutants of PCNA bind to Pol {lambda}. Figure 3B shows the schematic diagram of the deletion mutants for PCNA. From the results of a yeast two-hybrid assay, Pol {lambda} was shown to bind to the full-length PCNA, del1 and del4 but not to del2 and del3, suggesting that the central region containing ICL of PCNA is essential for binding to Pol {lambda}.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 3  Detection of the Pol {lambda} binding region in PCNA by a yeast two-hybrid assay. (A) Yeast Y190 cells were co-transformed with bait plasmid pAS2-1 or pAS2-1-Pol {lambda} and prey plasmid pACT2 or pACT2-PCNA and grown on selective DO2 plates. Direct binding was detected as ß-galactosidase activity by a colony-lift filter assay. (B) The full-length and deletion mutants of PCNA were examined for binding to Pol {lambda} by a yeast two-hybrid assay as described above. The column on the right (+/–) indicates a positive/negative result when tested for binding to Pol {lambda}.

 
TdT and Pol µ directly bind to PCNA through the conserved PIM

From the results showing that TdT and Pol {lambda} directly bind to PCNA (Ibe et al. 2001; present study) we expected that Pol µ, which also belongs to the family X, would also directly bind to PCNA. To prove this we attempted to examine their binding ability to PCNA by a GST pull-down assay. As shown in Fig. 4, as expected, Pol µ also directly bound to PCNA. Based on these findings, we further tested whether TdT and Pol µ also bind to PCNA through their C-terminal regions as well as Pol {lambda}. From these studies, using a GST pull-down assay, we found that the C-terminal 89 residues of TdT and the C-terminal 91 residues of Pol µ are responsible for PCNA binding (data not shown). We surveyed the amino acid sequences of TdT and Pol µ corresponding to the PCNA binding region in Pol {lambda} and found PIM like sequences, QRELRRFS at residues 441–448 in Pol µ and also ERDLRRYA at residues 456–463 in TdT (in which the conserved residues are indicated in bold type). Figure 5A shows the amino acid sequence alignment of the PIM-like sequences in TdT and Pol µ, the PCNA binding region in Pol {lambda} and the corresponding region of Pol ß. The hydropathy of the residues that are important for binding to PCNA is well conserved, especially the 7th aromatic residue that is critical within the PIM (Nakanishi et al. 1995; Warbrick et al. 1995). TdT and Pol µ conserve the 7th aromatic residue in the PIM like sequences as Y462 in TdT and F447 in Pol µ, whereas Pol {lambda} has L519, which is hydrophobic and not aromatic side chain, and Pol ß has H285 at the corresponding site. We then examined whether these regions in TdT and Pol µ actually work as the PCNA binding motifs by constructing mutants, in which Y462 in TdT and F447 in Pol µ were replaced with an A. As shown in Fig. 5B, lanes 2–5, their binding to PCNA was greatly reduced compared with that of the wild-type, strongly suggesting that TdT and Pol µ bind to PCNA through conserved motifs. It was also noticeable that the Pol {lambda} L519A mutant did not change its binding for PCNA (Fig. 5B, lanes 6 and 7), suggesting that Pol {lambda} binds to PCNA through different sequences with a conserved motif.



View larger version (52K):
[in this window]
[in a new window]
 
Figure 4  Binding between family X of DNA polymerases and PCNA in vitro. Glutathione Sepharose beads were mixed with purified recombinant PCNA and E. coli cell lysate expressing GST (lane 1), GST-Pol {lambda} (lane 2), GST-TdT (lane 3), GST- Pol {lambda} (lane 4) and GST-Pol µ (lane 5), respectively. Bound proteins were analyzed by immunoblotting with anti-GST or anti-PCNA antibodies. Lane 6 of the bottom panel contained 1/25 amount of purified PCNA used in the reaction.

 


View larger version (30K):
[in this window]
[in a new window]
 
Figure 5  Binding ability of TdT and Pol µ mutants to PCNA. (A) A partial amino acid sequence alignment of TdT and Pol µ corresponding to the PCNA binding region in Pol {lambda}. PIM like sequences in TdT and Pol µ are underlined and conserved residues consisting of the 8 amino acid sequences of PIM are indicated; Qxxhxxaa, where h is moderately hydrophobic side chains, a is highly hydrophobic, aromatic side chains and x is any residue. (B) Detection of direct binding between the wild-type (wt) and Alanin scanning mutants of Pol µ, TdT or Pol {lambda} and PCNA. Glutathione Sepharose beads were mixed with purified PCNA and E. coli cell lysate expressing GST (lane 1), GST-Pol µ wt (lane 2), GST-Pol µ F447A (lane 3), GST-TdT wt (lane 4), GST-TdT Y462A (lane 5), GST-Pol {lambda} wt (lane 6) and GST-Pol {lambda} L519A (lane 7), respectively. Bound proteins were analyzed by immunoblotting with anti-GST or anti-PCNA antibodies. Lane 8 of the bottom panel contained 1/25 amount of purified PCNA used in the reaction.

 
Pol {lambda} associates with PCNA in vivo

Next, to demonstrate association between Pol {lambda} and PCNA in vivo, we transiently over-expressed HA-tagged Pol {lambda} in HeLa cells and performed immunoprecipitation analysis with the cell extracts using specific antibodies against HA-tag bound to protein A Sepharose beads. The reaction mixture contained 100 µg/mL of ethidium bromide to inhibit DNA dependent protein–protein association (Lai & Herr 1992). Precipitated proteins were analyzed by Western blotting using specific antibodies against Pol {lambda} or PCNA. As shown in Fig. 6, PCNA was selectively co-precipitated with HA-Pol {lambda}. We also performed immunoprecipitation using intact HepG2 cell extracts with an anti-Pol {lambda} antibody. A faint protein band of PCNA was observed after Western blotting as the co-precipitants (data not shown) since the endogenous expression level of Pol {lambda} was very low. These results indicate that Pol {lambda} stably associates with PCNA in vivo as well as in vitro.



View larger version (42K):
[in this window]
[in a new window]
 
Figure 6  Pol {lambda} associates with PCNA in vivo. Lysate from HA-Pol {lambda} transfected HeLa cells was analyzed by immunoprecipitation and immunoblotting using indicated antibodies. A mock antibody indicates normal preimmune mouse serum used for the control reaction. Input lanes contain 1/10 and 1/40 amounts of the proteins used in the reaction at top and bottom panel, respectively.

 
Co-localization of Pol {lambda} and PCNA

From our findings that Pol {lambda} directly binds to PCNA in vivo as shown by immunoprecipitation analysis, we next asked whether Pol {lambda} co-localizes with PCNA in a cell. Initially, to clarify the cellular localization of Pol {lambda}, the cDNA-encoding enhanced green fluorescence protein (EGFP) was fused in-frame to the N-terminus of Pol {lambda} (EGFP-Pol {lambda}), and the construct was transiently transfected into HeLa cells. As shown in Fig. 7B, EGFP-Pol {lambda} was diffusely located within the nucleus with some brightly fluorescent spots. To exclude the possibility that the distribution of EGFP-Pol {lambda} was caused by artifacts derived from the EGFP-tag, we examined the distribution of untagged Pol {lambda} in a HeLa cell using a pcDNA-Pol {lambda} construct and monoclonal antibodies against Pol {lambda}. Since similar localizations of Pol {lambda} to those of EGFP-Pol {lambda} were observed (Fig. 7C), we concluded that this localization reflects the nuclear distribution of wild-type Pol {lambda}.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 7  Partial co-localization of Pol {lambda} and PCNA in HeLa nuclei. HeLa cells were transfected with plasmids encoding any (A) EGFP alone, (B) EGFP-Pol {lambda} or (C) untagged Pol {lambda}. The distribution of EGFP proteins was detected by autofluorescence of the EGFP. For visualization of untagged Pol {lambda}, cells were immunostained with monoclonal anti-Pol {lambda} antibody and Alexa Fluor 546 conjugated secondary antibody. (D) HeLa cells transfected with EGFP-Pol {lambda} were fixed and immunostained with PC10 and Alexa Fluor 546 conjugated secondary antibody (red staining). The distribution of EGFP-Pol {lambda} was detected by autofluorescence of the EGFP (green staining). Co-localization between EGFP-Pol {lambda} and PCNA is indicated by a yellow pattern.

 
Next, we attempted to examine whether Pol {lambda} co-localizes with PCNA in the nucleus. Staining of endogenous PCNA using specific antibodies against PCNA showed partial co-localization with EGFP-Pol {lambda} (Fig. 7D). During DNA replication, PCNA has been observed to form replication foci at the S phase nuclei (Nakamura et al. 1986; Leonhardt et al. 2000). Therefore, we asked whether Pol {lambda} localizes at the replication foci through association with PCNA. HeLa cells transiently expressing Pol {lambda} were pulse labeled with BrdU and replication foci were visualized using antibodies against BrdU. However, the spots of Pol {lambda} were not co-localized with those of BrdU, suggesting that Pol {lambda} does not participate in DNA replication at the S phase nuclei under normal conditions (data not shown).

PCNA negatively affects distributive nucleotidyltransferase activity of Pol {lambda}

Whereas the DNA polymerase activity of Pol {delta} dramatically increases by direct binding to PCNA, Pol {lambda} results in reduced dTMP incorporation into poly(dA)/oligo(dT) when used as a template-primer in the presence of PCNA (Shimazaki et al. 2002). As shown in Fig. 8A, Pol {lambda} showed distributive nucleotidyltransferase activity with 19-mer oligonucleotides primed to a 60-mer DNA, since DNA synthesis unlimitedly increased with increasing amounts of the enzyme. Biochemical studies have shown that PCNA promotes the stability of Pol {delta}/template-primer complexes without dissociation from the DNA end (Einolf & Guengerich 2000). Therefore, we suspected that Pol {lambda} is also stabilized on the template-primer by direct binding to PCNA, as seen in the case of Pol {delta}, and thus the Pol {lambda} transferase activity might ultimately be inhibited. We then examined the effect of PCNA on the Pol {lambda} transferase activity. As shown in Fig. 8B, DNA products synthesized were shortened with increasing amounts of PCNA, strongly suggesting that PCNA stabilizes Pol {lambda} onto the template-primer.



View larger version (47K):
[in this window]
[in a new window]
 
Figure 8  PCNA negatively regulates the distributive nucleotidyltransferase activity of Pol {lambda}in vitro. (A) Distributive nucleotidyltransferase activity of Pol {lambda}. Template-primer used was 5'-IRD-800 labeled 19-mer oligonucleotide annealed to a 60-mer oligonucleotide. Various amounts of Pol {lambda} were included in the reaction mixtures as described in the Experimental procedures. Reaction products were resolved on denaturing polyacrylamide gels. Lane 1 is the control with no enzyme and lanes 2, 3, 4 and 5 are 1, 2, 5 and 10 pmol of Pol {lambda}, respectively. The length of DNA is shown on the right side. (B) The effect of PCNA on the distributive nucleotidyl transferase activity of Pol {lambda}. The substrate was incubated with Pol {lambda} and PCNA, and the products were analyzed using denaturing polyacrylamide gels. Lane 1 is 10 pmol of Pol {lambda} alone and lanes 2, 3, 4 and 5 are 10 pmol of Pol {lambda} and 1, 5, 10 and 20 pmol of PCNA, respectively.

 

    Discussion
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Pol {lambda} has newly been identified as a member of the Pol X polymerases in mammalian cells (Aoufouchi et al. 2000; Garcia-Diaz et al. 2000; Nagasawa et al. 2000). Pol {lambda} has the most homologous amino acid sequence to that of Pol ß among the Pol X members and possesses both DNA-directed DNA polymerase and dRP lyase activities, but its biological function remains unclear. The direct binding of Pol {lambda} to PCNA in vitro (Shimazaki et al. 2002) led to us to investigate the functional role of the Pol {lambda}-PCNA complex. In this study, we have established that Pol {lambda} associates with PCNA in vivo, as well as in vitro. Pol {lambda} and PCNA form a stable complex in cells under physiological salt conditions as determined by immunoprecipitation analysis, and EGFP-Pol {lambda} shows partial co-localization with PCNA as spots in a HeLa cell nuclei. However, the spots of Pol {lambda} do not co-localize with those of BrdU, suggesting that Pol {lambda} does not participate in DNA replication at the S phase nuclei under normal conditions. Pol {lambda} is a low processive and error-prone DNA polymerase, with low fidelity and high frame-shift infidelity (Bebenek et al. 2003). Therefore, it is conceivable that Pol {lambda} does not participate in processive DNA replication, which relies on DNA polymerases with high processivity and high fidelity (e.g. Pol {delta}, Pol {varepsilon}).

The proteins that directly bind to PCNA usually possess a consensus PCNA interacting motif PIM; [Q1X2X3(L/I/M)4X5X6F7(F/Y)8] at the N- or C-terminus (Tsurimoto 1999; Warbrick 2000). In particular, M4 and F7 of the PIM in the regulatory protein of the cell-cycle dependent kinase p21 are crucial for recognition of PCNA (Nakanishi et al. 1995; Warbrick et al. 1995). Recently, Xu et al. (2001) identified a novel PCNA binding motif, termed the KA-box [KA-(A/L/I)-(A/L/Q)-x-x-(L/V)], using a proteomics approach with a random peptide library. This motif is also present in several PCNA binding proteins (e.g. Pol {delta}, Pol {varepsilon}, RFC). However, the other proteins without these consensus motifs (e.g. CAF-1 p150, GADD45) also directly bind to PCNA (Warbrick 2000). In the present study, Pol {lambda} has been revealed to have a novel PCNA binding region in its C-terminal region, which is related to neither the PIM nor the KA-box. According to the crystal structure of the C-terminal half of the human Pol {lambda}-gapped DNA complex (Garcia-Diaz et al. 2004), the region corresponding to the PCNA binding region in Pol {lambda} (residues 508–563) contains a long loop protruding on the surface of Pol {lambda} (Fig. 9). Furthermore, the region corresponding to the Pol {lambda} peptide LP518 (residues 518–537) contains ß-strands 6, 7 and the N-terminus of the long loop structure, which is buried in the vicinity of the DNA. Interestingly, the loop in Pol {lambda} is larger than that of Pol ß and includes a ß-strand 8 that is not present in other Pol X members. Therefore, we could expect that these unique structures of Pol {lambda} are crucial for binding to PCNA.



View larger version (36K):
[in this window]
[in a new window]
 
Figure 9  Crystal structure image of the C-terminal half of human Pol {lambda}/gapped DNA. The PCNA binding region in Pol {lambda}, determined by GST-pull down assay using deletion mutants of Pol {lambda}, is illustrated in magenta (residues 508–563) and the region corresponding to the Pol {lambda} peptide LP518 is illustrated in red (residues 518–537). A two nucleotide gapped DNA is illustrated in blue (template), cyan (primer) and green (downstream primer). A front view is shown on the left and a side view is shown on the right. The Pol {lambda} structure was generated using the program rasmol from the PDB file 1 rzt.

 
From the three dimensional structure of human PCNA complexed with a peptide derived from the C-terminal region of p21, the peptide binds to PCNA in an almost fully extended conformation across one surface of each PCNA subunit, resulting in an interaction through the interdomain-connecting loop (ICL) of PCNA (Gulbis et al. 1996). Proteins with PIM are commonly considered to bind to a hydrophobic pocket on the surface of PCNA (Tsurimoto 1999). Despite lacking a consensus motif in Pol {lambda}, the results of the yeast two-hybrid assay strongly suggest that the central region of PCNA containing the ICL is involved in binding to Pol {lambda}. Since human PCNA forms a homo-trimeric ring, it is possible that three different molecules could bind to the surface of PCNA. Then, we examined the stoichiometry of the Pol {lambda}-PCNA complex using a BMH cross-linker. We detected three forms of PCNA (monomer; 32 kDa) by SDS-PAGE after BMH cross-linking analysis as the control. When Pol {lambda} (monomer; 68 kDa) was added to the PCNA solution, a clear band was observed at a position of 160 kDa after cross-linking, which coincides with the stoichiometry of one molecule of a Pol {lambda}/a PCNA trimer (date not shown).

PCNA has been well characterized as an auxiliary protein for Pol {delta}, which functions as an essential component for chromosomal DNA replication. Processivity of Pol {delta} depends entirely on PCNA, by holding enzymes on a template-primer end of replicative DNA without dissociation. Recent studies have shown that PCNA is involved in many aspects of DNA transaction, forming a sliding platform that can mediate the protein–protein interaction (Tsurimoto 1999; Warbrick 2000). The family Y DNA polymerases Pol {eta}, {iota} and {kappa}, which are believed to function in translesion DNA synthesis, have also been revealed to bind directly to PCNA. PCNA slightly promotes family Y DNA polymerase activity by reduction of the Km value together with replication factor C (RFC) and replication protein A (RPA) (Haracska et al. 2001a,b,c, 2002). In the case of Pol {lambda}, Pol {lambda} transferase activity was decreased in the presence of PCNA without other associated components. PCNA fundamentally functions as DNA sliding clamp and stabilizes the DNA polymerase/template-primer complex to enhance DNA polymerase activity, such as Pol {delta}, when it works in a processive manner. On the other hand, we hypothesize that the same function of PCNA, which stabilizes the DNA polymerase/template-primer complex, offers negative effects on DNA polymerase when it works in a distributive manner; namely, after addition of a nucleotide to the primer end, the DNA polymerase is released from the site without being held at the template-primer end.

We showed that Pol µ, which has also recently been identified as a Pol X polymerase and has a highly homologous amino acid sequence to TdT, also directly binds to PCNA. TdT and Pol µ have their own PCNA binding regions and are different to that of Pol {lambda}. When the residues with an aromatic side chain in the PIM like sequence within Pol µ and TdT, which are considered to be essential for binding to PCNA, were mutated, binding of TdT and Pol µ to PCNA greatly reduced. Ibe et al. reported that TdT directly binds to PCNA through the entire Pol ß-like region as determined by a yeast two-hybrid assay after construction of a series of TdT deletion mutants (Ibe et al. 2001). In our findings, however, the confined region containing the PIM in TdT directly bound to PCNA, and when the amino acid in the PIM was mutated direct binding between them was reduced, as determined by a pull-down assay, indicating that binding is through the conserved PIM. The difference in binding regions is considered to be due to the different analysis methods used, namely a yeast two-hybrid assay in vivo and a pull-down assay in vitro. Based on our findings showing that TdT, Pol {lambda} and Pol µ directly bind to PCNA, we tested whether the Pol {lambda} peptide also competes with TdT and Pol µ for binding to PCNA. As a result, no inhibitory effect was observed with regards to their binding to PCNA (data not shown). By yeast two-hybrid screening using TdT as bait, the C-terminal region of PCNA was isolated, but this did not include the ICL of PCNA. In the present work, we showed that the central region containing the ICL of PCNA is involved in binding to Pol {lambda} by the yeast two-hybrid assay. Therefore, it is reasonable to assume that TdT and Pol µ do not compete with Pol {lambda} for binding to PCNA. These facts raise the possibility that Pol X polymerases could bind to PCNA individually without competing with each other and might form a large complex through the PCNA.

Three members of Pol X polymerase, TdT, Pol {lambda} and Pol µ, are candidates for processing in NHEJ of repairing DSBs. TdT is a lymphoid specific enzyme and its expression is restricted to immature lymphocytes. TdT can synthesize DNA in a template independent manner and specifically add extra nucleotides at the junctions between V and D or between D and J segments during V(D)J recombination, which is a specialized form of NHEJ (Gilfillan et al. 1993; Komori et al. 1993). Pol µ has been reported to associate with Ku, the XRCC4-LigIV complex, which are core NHEJ components (Mahajan et al. 2002). Moreover, a genetic knockout study of Pol µ revealed that Pol µ is involved in immunoglobulin light chain gene rearrangement, indicating that Pol µ functions in V(D)J recombination (Bertocci et al. 2003). From other approaches used to investigate which Pols are involved in the NHEJ, Pol {lambda} has been shown to be required for gap-filling and end-joining in NHEJ together with the XRCC4-LigIV complex, as determined by immunodepletion analysis using HeLa cell extracts (Lee et al. 2004). Very recently, Ma et al. (2004) demonstrated that three members of Pol X polymerase, TdT, Pol {lambda} and Pol µ, specifically contribute to the processing of NHEJ together with Ku and the XRCC4-LigIV complex using a biochemically defined in vitro NHEJ system. Therefore, based on these facts and our findings showing that Pol {lambda}, TdT and Pol µ directly bind to PCNA, we suspect that PCNA regulates the polymerization activities of these Pols at the DSB junction. This hypothesis is supported by evidence that DNA-PKcs and Ku70/80, core NHEJ components, were recovered from eluted nuclear extracts of a human cell after PCNA fixed resin affinity chromatography (Ohta et al. 2002). These observations strongly suggest that PCNA plays a significant role in NHEJ of DSBs.

In conclusion, we have shown that human Pol {lambda} directly binds to PCNA through its C-terminal region both in vitro and in vivo. The consequence of the binding is negative regulation of its nucleotidyltransferase activity. We also found that the three members of Pol X polymerase, TdT, Pol {lambda} and Pol µ, directly bind to PCNA.


    Experimental procedures
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Construction and expression of recombinant proteins

Construction of Pol {lambda} and PCNA expression vectors, and expression and purification of the protein have all been previously described (Ibe et al. 2001; Shimazaki et al. 2002). Cloning of full-length cDNA for human TdT has also been previously described (Ibe et al. 2001).

Full-length cDNA for human Pol µ was amplified by the polymerase chain reaction (PCR) using the primers M-F1 (5'-GAAGAATTCATGCTCCCCAAACGGCGGCGAGCG-3') and M-R1 (5'-GCACTCGAGGGCGTTTCTCTGCTCTGGAGGAAG-3') from a human placenta cDNA library (Clontech). M-F1 contains a EcoRI site and M-R1 contains a XhoI site, respectively (underlined). PCR was performed following a standard procedure.

Site-directed mutantagenesis of Pol {lambda} and TdT was performed by PCR using a Quick Change site-directed mutagenesis kit from Stratagene. A pair of mutagenic primers was used for the Pol {lambda} mutant L519A (5'-CGCTCCATGCGAGCGGCGGCCAAAACCAAGGG-3' and 5'-CCCTTGGTTTTGGCCGCGGCTCGCATGGAGCG-3') and for the TdT mutant Y462A the primers 5'-AGAGACCTCCGGCGCGCTGCCACACATGAGCG-3' and 5'-CGCTCATGTGTGGCAG CGCGCCGGAGGTCTCT-3' were used. Pol µ mutant F477A was generated by PCR using a pair of mutagenic primers (5'-AAGCTTTTCCAGCGGGAGCTGCGCCGCGCCAGCC-3' and 5'-GCACTCGAGGGCGTTTCTCTGCTCTGGAGGAAG-3'). A cDNA fragment of the Pol µ mutant was substituted with the corresponding region of wild-type cDNA for Pol µ. The nucleotide sequences were determined by the dideoxy termination method. The cDNA fragments containing wild-types or each mutation were subcloned into pGEX vectors (Amersham Bioscience).

Full-length cDNA for Pol {lambda} was subcloned into EcoRI and SalI sites of pEGFP-C2 vector (Clontech) to produce EGFP tagged protein and a pcDNA vector (Invitrogen) to produce untagged protein.

Antibodies

Rabbit polyclonal and mouse monoclonal antibodies against Pol {lambda} were produced by immunization with the recombinant Pol {lambda} using a standard procedure. Monoclonal anti-PCNA antibody (PC10) was purchased from Dako, monoclonal anti-HA tag antibody from MBL and rabbit polyclonal anti-GST antibody was from ABR Inc. The secondary antibodies for immunoblotting, namely horseradish peroxidase (HRP) conjugated goat anti-mouse IgG antibody and HRP conjugated horse anti-mouse IgG antibody, were purchased from New England Biolabs. The secondary antibodies used for immunofluorescence, namely Alexa Fluor 546 F(ab')2 fragment of goat anti-mouse IgG (H+L), was purchased from Molecular Probe.

GST pull-down assay

A GST pull-down assay was performed according to previously described methods (Shimazaki et al. 2002). E. coli cells expressing GST or GST fused proteins were lyzed and the crude cell extracts were mixed with 0.5 µg of purified PCNA in binding buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM DTT, 0.1% Nonidet P-40, 10% glycerol, 0.1% BSA, 1 mM PMSF, 1 mM benzamidine, 10 µg/mL aprotinin, 5 µg/mL leupeptin and 2 µg/mL pepstatin A). The protein complex was coupled to Glutathione Sepharose beads (Amersham Bioscience) and binding proteins were separated by SDS-PAGE. Following transfer onto nitrocellulose membrane, immunoblotting was performed with both anti-GST and anti-PCNA antibodies.

For the competition experiments, 20-mer peptides (LP508, LP513 and LP518) were synthesized to cover the C-terminus of Pol {lambda} (QIAGEN). Each peptide was dissolved in water to a final concentration of 2–10 mg/mL and stored at –80 °C. To examine whether the full-length Pol {lambda} and synthetic peptides compete for binding to PCNA, a GST pull-down assay was performe with full-length Pol {lambda} and PCNA in the presence of increasing amounts of the peptides. Binding proteins were separated by SDS-PAGE and analyzed by immunoblotting with both anti-GST and anti-PCNA antibodies.

Yeast two-hybrid assay

Yeast Y190 cells were co-transformed with bait plasmids pAS2-1 or pAS2-1-Pol {lambda} and prey plasmids pACT2, pACT2-PCNA or pACT2-PCNA deletion mutants and grown on selective DO2 plates. Protein–protein interactions were determined by a ß-galactosidase assay according to the manufacturer's protocol (MATCH MAKER II from Clontech).

Cell culture and transfection

HeLa cells were grown at 37 °C under a humidified atmosphere containing 5% CO2 with Dalbecco's modified Eagle's medium (Gibco BRL) supplemented with 10% foetal bovine serum. Transfection of plasmid DNA was carried out using Lipofect AMINE plus (Invitrogen) according to the manufacturer's protocol. All operations were carried out at room temperature.

Immunoprecipitation

HeLa cells transfected with HA-Pol {lambda} expressing plasmids were harvested and washed with PBS. Cells were lyzed on ice with lysis buffer (25 mM HEPES-KOH, pH 7.4, 200 mM NaCl, 1% NP40, 10% glycerol, 1 mM DTT, 1 mM PMSF, 1 mM benzamidine, 10 µg/mL aprotinin, 5 µg/mL leupeptin and 2 µg/mL pepstatin A) and centrifuged. Anti-HA tag antibody or normal mouse IgG that bound to protein A Sepharose beads (Amersham Bioscience) were added to the soluble cell extract, and binding was allowed to proceed for 2 h at 4 °C. After washing extensively with the same buffer, the immunobeads were denatured in SDS sample buffer, fractionated on a 10% SDS-PAGE gel, and then analyzed by immunoblotting with both anti-Pol {lambda} and anti-PCNA antibodies.

Immunofluorescence microscopy

HeLa cells were grown on coverslips and transfected with plasmids encoding EGFP or untagged Pol {lambda}. All operations were carried out at room temperature unless otherwise indicated. For visualization of EGFP-Pol {lambda}, the cells transfected with EGFP-Pol {lambda} were rinsed twice in PBS and fixed with cold methanol, then mounted with PBS containing 4,6-diamidio-2-phenylindole (DAPI). For detection of untagged Pol {lambda}, fixed cells with cold methanol were incubated with 1% BSA in PBS for 30 min and subsequently reacted with monoclonal Pol {lambda} antibody, followed by Alexa Fluor 546 conjugated goat anti-mouse IgG. For detection of PCNA, fixed cells with cold methanol and acetone were blocked with 1% BSA in PBS and subsequently reacted with PC10, followed by Alexa Fluor 546 conjugated goat anti-mouse IgG. The cells were imaged on an Axiovert 200 microscope with an AxioCam HRc (Carl Zeiss).

In vitro primer extension assay

5'-IRD800 dATP labeled M13 forward (-29) primer 5'-CACGACGTTGTAAAACGAC-3' (LI-COR) was annealed to a 60 mer template oligonucleotide 5'-CTCTAGAGTCGACCTGCAGGCATGCATGCAAGCTTGGCACTGGCCGTCGTTTTACAACGTCGTG-3' in a stoichiometric ratio of 1 : 1. The reaction mixture (10 µL) contained 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 2 mM MgCl2, 1 mM DTT, 200 µg/mL BSA, 5 µM dTTP, 1 pmol of template-primer and proteins as indicated in Fig. 8. The reaction mixture was incubated at 37 °C for 30 min and then stopped by adding formamide gel loading solution. The products were resolved on a 9% Long ranger (FMC) gel containing 8 M urea and visualized using a dNA Analyzer Gene Reader 4200 (ALOKA).


    Acknowledgements
 
We would like to gratefully acknowledge the support of the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists to NS.


    Footnotes
 
Communicated by: Kozo Kaibuchi

* Correspondence: E-mail: snoriko{at}rs.noda.tus.ac.jp


    References
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Aoufouchi, S., Flatter, E., Dahan, A., et al. (2000) Two novel human and mouse DNA polymerases of the polX family. Nucleic Acids Res. 28, 3684–3693.[Abstract/Free Full Text]

Aravind, L. & Koonin, E.V. (1999) DNA polymerase beta-like nucleotidyltransferase superfamily: identification of three new families, classification and evolutionary history. Nucleic Acids Res. 27, 1609–1618.[Abstract/Free Full Text]

Bebenek, K., Garcia-Diaz, M., Blanco, L. & Kunkel, T.A. (2003) The frameshift infidelity of human DNA polymerase lambda. Implications for function. J. Biol. Chem. 278, 34685–34690.[Abstract/Free Full Text]

Bertocci, B., Smet, A., Berek, C., Weill, J.C. & Reynaud, C.A. (2003) Immunoglobulin kappa light chain gene rearrangement is impaired in mice deficient for DNA polymerase mu. Immunity 19, 203–211.[CrossRef][Medline]

Braithwaite, D.K. & Ito, J. (1993) Compilation, alignment and phylogenetic relationships of DNA polymerases. Nucleic Acids Res. 21, 787–802.[Free Full Text]

Burgers, P.M., Koonin, E.V. & Bruford, E. (2001) Eukaryotic DNA polymerases: proposal for a revised nomenclature. J. Biol. Chem. 276, 43487–43490.[Free Full Text]

Dominguez, O., Ruiz, J.F., Lain de Lera, T., et al. (2000) DNA polymerase mu (Pol µ), homologous to TdT, could act as a DNA mutator in eukaryotic cells. EMBO J. 19, 1731–1742.[CrossRef][Medline]

Einolf, H.J. & Guengerich, F.P. (2000) Kinetic analysis of nucleotide incorporation by mammalian DNA polymerase delta. J. Biol. Chem. 275, 16316–16322.[Abstract/Free Full Text]

Garcia-Diaz, M., Bebenek, K., Krahn, J.M., Blanco, L., Kunkel, T.A. & Pedersen, L.C. (2004) A structural solution for the DNA polymerase lambda-dependent repair of DNA gaps with minimal homology. Mol. Cell 13, 561–572.[CrossRef][Medline]

Garcia-Diaz, M., Bebenek, K., Kunkel, T.A. & Blanco, L. (2001) Identification of an intrinsic 5'-deoxyribose-5-phosphate lyase activity in human DNA polymerase lambda: a possible role in base excision repair. J. Biol. Chem. 276, 34659–34663.[Abstract/Free Full Text]

Garcia-Diaz, M., Bebenek, K., Sabariegos, R., et al. (2002) DNA polymerase lambda, a novel DNA repair enzyme in human cells. J. Biol. Chem. 277, 13184–13191.[Abstract/Free Full Text]

Garcia-Diaz, M., Dominguez, O., Lopez-Fernandez, L.A., et al. (2000) DNA polymerase lambda (Pol lambda), a novel eukaryotic DNA polymerase with a potential role in meiosis. J. Mol. Biol. 301, 851–867.[CrossRef][Medline]

Gilfillan, S., Dierich, A., Lemeur, M., Benoist, C. & Mathis, D. (1993) Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 261, 1175–1178.[Abstract/Free Full Text]

Gulbis, J.M., Kelman, Z., Hurwitz, J., O'Donnell, M. & Kuriyan, J. (1996) Structure of the C-terminal region of p21 (WAF1/CIP1) complexed with human PCNA. Cell 87, 297–306.[CrossRef][Medline]

Haracska, L., Johnson, R.E., Unk, I., et al. (2001b) Physical and functional interactions of human DNA polymerase eta with PCNA. Mol. Cell. Biol. 21, 7199–7206.[Abstract/Free Full Text]

Haracska, L., Johnson, R.E., Unk, I., et al. (2001c) Targeting of human DNA polymerase iota to the replication machinery via interaction with PCNA. Proc. Natl. Acad. Sci. USA 98, 14256–14261.[Abstract/Free Full Text]

Haracska, L., Kondratick, C.M., Unk, I., Prakash, S. & Prakash, L. (2001a) Interaction with PCNA is essential for yeast DNA polymerase eta function. Mol. Cell 2, 407–415.

Haracska, L., Unk, I., Johnson, R.E., et al. (2002) Stimulation of DNA synthesis activity of human DNA polymerase kappa by PCNA. Mol. Cell. Biol. 22, 784–791.[Abstract/Free Full Text]

Hubscher, U., Nasheuer, H.P. & Syvaoja, J.E. (2000) Eukaryotic DNA polymerases, a growing family. Trends Biochem. Sci. 25, 143–147.[CrossRef][Medline]

Ibe, S., Fujita, K., Toyomoto, T., et al. (2001) Terminal deoxynucleotidyltransferase is negatively regulated by direct interaction with proliferating cell nuclear antigen. Genes Cells 9, 815–824.

Ito, J. & Braithwaite, D.K. (1991) Compilation and alignment of DNA polymerase sequences. Nucleic Acids Res. 19, 4045–4057.[Free Full Text]

Jonsson, Z.O., Hindges, R. & Hubscher, U. (1998) Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen. EMBO J. 17, 2412–2425.[CrossRef][Medline]

Kobayashi, Y., Watanabe, M., Okada, Y., et al. (2002) Hydrocephalus, situs inversus, chronic sinusitis, and male infertility in DNA polymerase lambda-deficient mice: possible implication for the pathogenesis of immotile cilia syndrome. Mol. Cell. Biol. 22, 2769–2776.[Abstract/Free Full Text]

Komori, T., Okada, A., Stewart, V. & Alt, F.W. (1993) Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 261, 1171–1175.[Abstract/Free Full Text]

Lai, J.S. & Herr, W. (1992) Ethidium bromide provides a simple tool for identifying genuine DNA–independent protein associations. Proc. Natl. Acad. Sci. U S A 89, 6958–6962.[Abstract/Free Full Text]

Lee, J.W., Blanco, L., Zhou, T., et al. (2004) Implication of DNA polymerase lambda in alignment-based gap filling for nonhomologous DNA end joining in human nuclear extracts. J. Biol. Chem. 279, 805–811.[Abstract/Free Full Text]

Leonhardt, H., Rahn, H.P., Weinzierl, P., et al. (2000) Dynamics of DNA replication factories in living cells. J. Cell Biol. 149, 271–280.[Abstract/Free Full Text]

Ma, Y., Lu, H., Tippin, B., et al. (2004) A biochemically defined system for mammalian nonhomologous DNA end joining. Mol. Cell 16, 701–713.[CrossRef][Medline]

Mahajan, K.N., Nick McElhinny, S.A., Mitchell, B.S. & Ramsden, D.A. (2002) Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol. Cell. Biol. 22, 5194–5202.[Abstract/Free Full Text]

Marini, F., Kim, N., Schuffert, A. & Wood, R.D. (2003) POLN, a nuclear Pol A family DNA polymerase homologous to the DNA cross-link sensitivity protein Mus308. J. Biol. Chem. 278, 32014–32019.[Abstract/Free Full Text]

Matsumoto, Y. & Kim, K. (1995) Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 269, 699–702.[Abstract/Free Full Text]

Nagasawa, K., Kitamura, K., Yasui, A., et al. (2000) Identification and characterization of human DNA polymerase beta2, a DNA polymerase beta-related enzyme. J. Biol. Chem. 275, 31233–31238.[Abstract/Free Full Text]

Nakamura, H., Morita, T. & Sato, C. (1986) Structural organizations of replicon domains during DNA synthetic phase in the mammalian nucleus. Exp. Cell Res. 165, 291–297.[CrossRef][Medline]

Nakanishi, M., Robetorye, R.S., Pereira-Smith, O.M. & Smith, J.R. (1995) The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J. Biol. Chem. 270, 17060–17063.[Abstract/Free Full Text]

Ohmori, H., Friedberg, E.C., Fuchs, R.P., et al. (2001) The Y-family of DNA polymerases. Mol. Cell 8, 7–8.[CrossRef][Medline]

Ohta, S., Shiomi, Y., Sugimoto, K., Obuse, C. & Tsurimoto, T. (2002) A proteomics approach to identify proliferating cell nuclear antigen (PCNA) -binding proteins in human cell lysates. Identification of the human CHL12/RFCs2–5 complex as a novel PCNA-binding protein. J. Biol. Chem. 277, 40362–40367.[Abstract/Free Full Text]

Piersen, C.E., Prasad, R., Wilson, S.H. & Lloyd, R.S. (1996) Evidence for an amino intermediate in the DNA polymerase beta deoxyribose phosphate excision reaction. J. Biol. Chem. 271, 17811–17815.[Abstract/Free Full Text]

Shimazaki, N., Yoshida, K., Kobayashi, T., Toji, S., Tamai, K. & Koiwai, O. (2002) Over-expression of human DNA polymerase lambda in E. coli and characterization of the recombinant enzyme. Genes Cells 7, 639–651.[Abstract]

Tsurimoto, T. (1999) PCNA binding proteins. Front. Biosci. 4, D849–D858.[Medline]

Wang, Z., Castano, I.B., De Las Penas, A., Adams, C. & Christman, M.F. (2000) Pol kappa: a DNA polymerase required for sister chromatid cohesion. Science 289, 774–779.[Abstract/Free Full Text]

Warbrick, E. (2000) The puzzle of PCNA's many partners. Bioessays 22, 997–1006.[CrossRef][Medline]

Warbrick, E., Lane, D.P., Glover, D.M. & Cox, L.S. (1995) A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5, 275–282.[CrossRef][Medline]

Wilson, S.H. (1998) Mammalian base excision repair and DNA polymerase beta. Mutat. Res. 407, 203–215.

Xu, H., Zhang, P., Liu, L. & Lee, M.Y. (2001) A novel PCNA-binding motif identified by the panning of a random peptide display library. Biochemistry 40, 4512–4520.[CrossRef][Medline]

Received: 28 February 2005
Accepted: 29 March 2005




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
B. Velmurugan, R. P. Singh, A. Tyagi, and R. Agarwal
Inhibition of Azoxymethane-Induced Colonic Aberrant Crypt Foci Formation by Silibinin in Male Fisher 344 Rats
Cancer Prevention Research, October 1, 2008; 1(5): 376 - 384.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
S. Fujisaki, A. Sato, T. Toyomoto, T. Hayano, M. Sugai, T. Kubota, and O. Koiwai
Direct binding of TReP-132 with TdT results in reduction of TdT activity
Genes Cells, January 1, 2006; 11(1): 47 - 57.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
I. Frouin, M. Toueille, E. Ferrari, I. Shevelev, and U. Hubscher
Phosphorylation of human DNA polymerase {lambda} by the cyclin-dependent kinase Cdk2/cyclin A complex is modulated by its association with proliferating cell nuclear antigen
Nucleic Acids Res., September 20, 2005; 33(16): 5354 - 5361.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimazaki, N.
Right arrow Articles by Koiwai, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimazaki, N.
Right arrow Articles by Koiwai, O.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS